Actively Recruiting
Conquering Fear Online: Pilot Randomised Controlled Trial of an Internet-based Self-management Intervention for Subclinical Fear of Cancer Recurrence
Led by The University of Hong Kong · Updated on 2025-10-03
48
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
Sponsors
T
The University of Hong Kong
Lead Sponsor
H
Health and Medical Research Fund
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating an internet-based self-management program called eConquerFear-HK designed to reduce fear of cancer recurrence in local Chinese cancer survivors who have subclinical levels of fear. This pilot randomized controlled trial aims to test the feasibility, usefulness, and potential effects of this program compared to an active control group receiving general lifestyle guidance. The study focuses on survivors of colorectal or breast cancer who have completed primary surgery and hospital-based adjuvant treatments recently. Participants in the eConquerFear-HK group will access six online modules covering topics such as worry control, attention training, mindfulness, values-based goal setting, and relapse prevention. These modules include educational text, graphics, exercises, and videos. The comparison group will watch six videos offering general advice on relaxation, diet, and physical activity to support long-term health. Both interventions are delivered entirely online. During the study, researchers will monitor recruitment and retention rates, adherence to the interventions, and participant satisfaction. They will also assess changes in fear of cancer recurrence, psychological distress, quality of life, and metacognition at baseline, immediately after the intervention, and at 3- and 6-month follow-ups. The total study duration and detailed schedules are based on these timepoints, aiming to understand the usefulness and impact of eConquerFear-HK in managing cancer survivors' fears.
CONDITIONS
Brief Title
E-intervention on Subclinical Fear of Cancer Recurrence
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Cantonese- or Mandarin-speaking Chinese cancer survivors
- Recently diagnosed with potentially curable (stage 0 to III) colorectal or breast cancer
- Recently completed surgery as primary treatment
- Completed hospital-based adjuvant treatments within the past six months
- Scored 13 to 21 on the fear of cancer recurrence-short form
You will not qualify if you...
- Non-Chinese ethnicity
- Metastatic cancer
- Current diagnosis of depression or psychosis or currently receiving psychological treatments
- Language or intellectual difficulties preventing understanding of the intervention
- Limited or no Internet access
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 6 weeks
Participants receive either the eConquerFear-HK online self-management intervention or Basic Cancer Care videos to help manage fear of cancer recurrence and support health maintenance.
6 weekly online sessions
Duration - 6 months
Participants are monitored to assess the effectiveness of the intervention on fear of cancer recurrence, psychological distress, quality of life, and treatment satisfaction.
Visits at immediate post-intervention, 3 months post-intervention, and 6 months post-intervention
Trial Site Locations
Total: 1 location
1
Queen Mary Hospital-Department of Surgery
Hong Kong, Hong Kong
Actively Recruiting
Research Team
D
Danielle Ng, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here